Development and Validation of a Multimodal Artificial Intelligence–derived Digital Pathology–based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG Trials

20251 citationsJournal Articlehybrid Open Access

Authors

Todd M. Morgan · Michigan Center for Translational Pathology

Yi Ren

Jeffry Simko · University of California San Francisco Medical Center

Sandy DeVries · University of California San Francisco Medical Center

Alan Pollack

Abstract

The post-RP MMAI model provides individualized risk estimates after SRT ± HT and may support shared decision-making about salvage treatment. External and prospective validation are ongoing.

Topics & Keywords

Prostate Cancer Diagnosis and Treatment Prostate Cancer Treatment and Research Radiomics and Machine Learning in Medical Imaging

UN Sustainable Development Goals

Peace, Justice and strong institutions

Publication Details

Published in: European Urology

DOI: 10.1016/j.eururo.2025.12.007

Field-Weighted Citation Impact: 1.51